Aller au contenu principal
Accès ouvert déclaré 2022 article

No accelerated arterial aging in relatively young women after preeclampsia as compared to normotensive pregnancy

3Citations signalées, ce qui n’est pas une note de qualité
6Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : nl. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Introduction Preeclampsia, an endothelial disorder of pregnancy, predisposes to remote cardiovascular diseases (CVD). Whether there is an accelerated effect of aging on endothelial decline in former preeclamptic women is unknown. We investigated if the arterial aging regarding endothelial-dependent and -independent vascular function is more pronounced in women with a history of preeclampsia as compared to women with a history of solely normotensive gestation(s). Methods Data was used from the Queen of Hearts study (ClinicalTrials.gov Identifier NCT02347540); a large cross-sectional study on early detection of cardiovascular disease among young women (≥18 years) with a history of preeclampsia and a control group of low-risk healthy women with a history of uncomplicated pregnancies. Brachial artery flow-mediated dilation (FMD; absolute, relative and allometric) and sublingually administered nitroglycerine-mediated dilation (NGMD; absolute and relative) were measured using ultrasound. Cross-sectional associations of age with FMD and NGMD were investigated by linear regression. Models were adjusted for body mass index, smoking, antihypertensive drug use, mean arterial pressure, fasting glucose, menopausal state, family history of CVD and stress stimulus during measurement. Effect modification by preeclampsia was investigated by including an interaction term between preeclampsia and age in regression models. Results Of the 1,217 included women (age range 22–62 years), 66.0% had a history of preeclampsia and 34.0% of normotensive pregnancy. Advancing age was associated with a decrease in relative FMD and NGMD (unadjusted regression coefficient: FMD: −0.48%/10 years (95% CI:−0.65 to −0.30%/10 years), NGMD: −1.13%/10 years (−1.49 to −0.77%/10 years)) and increase in brachial artery diameter [regression coefficient = 0.16 mm/10 years (95% CI 0.13 to 0.19 mm/10 years)]. Similar results were found when evaluating FMD and NGMD as absolute increase or allometrically, and after confounder adjustments. These age-related change were comparable in former preeclamptic women and controls (p-values interaction ≥0.372). Preeclampsia itself was independently associated with consistently smaller brachial artery diameter, but not with FMD and NGMD. Conclusion In young- to middle-aged women, vascular aging in terms of FMD and NGMD was not accelerated in women after preeclampsia compared to normotensive pregnancies, even though former preeclamptic women consistently have smaller brachial arteries.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
No accelerated arterial aging in relatively young women after preeclampsia as compared to normotensive pregnancy
Date Crossref
28/07/2022
Éditeur
Frontiers Media SA
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Maastricht University Medical Centre Cardiovascular Research Institute Maastricht (CARIM) pays non établi dans la notice
    Organisme public
  • Maastricht University pays non établi dans la notice
    Université ou école supérieure
  • Zuyderland Medisch Centrum pays non établi dans la notice
    Établissement de santé
  • Care and Public Health Research Institute pays non établi dans la notice
    Structure de recherche
  • Radboud University Nijmegen pays non établi dans la notice
    Université ou école supérieure
  • Radboud University Medical Center pays non établi dans la notice
    Organisme public
  • Department of Biomedical Engineering pays non établi dans la notice
    Institution
  • Department of Clinical Epidemiology and Medical Technology Assessment pays non établi dans la notice
    Établissement de santé
  • Department of Cardiology pays non établi dans la notice
    Institution
  • Department of Intensive Care Medicine pays non établi dans la notice
    Institution
  • Radboud University Medical Centre Department of Obstetrics and Gynaecology pays non établi dans la notice
    Université ou école supérieure

Cardiovascular Research Institute Maastricht (CARIM) — Maastricht University Medical Centre, Maastricht University et Zuyderland Medisch Centrum, avec 8 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pregnancy and preeclampsia studiesCardiovascular Health and Disease PreventionPeripheral Artery Disease Management

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.